Search
01/03/2025
USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY
Chico, A, Ampudia-Blasco, FJ, Daín, A, Scheibner, K, Dagenbach, N, Grifoll-Romero, L, Barmaymon, D, Vogt, G, Best, J, Etter, T. USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/02/2022
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Christ-Crain M, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, Valassi E., Wierman, Margaret E.. Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas. Pituitary. 2022; 25(1)DOI:10.1007/s11102-021-01170-3. PMID:34283370. IF:3.800(Q2/5D).
01/09/2021
Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.
Calderon-Mediavilla M, Vila-Badia R, Dolz M, Butjosa A, Barajas A, Del Cacho N, Sánchez B, Pardo M, Baños I, Usall J, Ochoa S, Santos, A, Nunez, C, Soler, A.. Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 30(9)DOI:10.1007/s00787-020-01618-0. PMID:32865655. IF:5.349(Q1/1D).
01/02/2026
Oxytocin levels do not change around a meal and correlate with reward-driven caloric consumption in adults with obesity
Wronski, M, Boutin, R, Sailer, CO, Galbiati, F, Aulinas, A, Muhammed, M, Eddy, KT, Thomas, JJ, Kerem, L, Carter, CS, Nazarloo, S, Davis, JM, Blevins, JE, Holman, K, Gydus, J, Smith, SE, Asanza, E, Plessow, F, Lawson, EA. Oxytocin levels do not change around a meal and correlate with reward-driven caloric consumption in adults with obesity. DIABETES OBESITY & METABOLISM. 2026; 28(2)DOI:10.1111/dom.70340. PMID:41392857. IF:5.700(Q1/2D).
08/01/2026
Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview
Gil, J, de Pedro-Campos, P, Carrato, C, Jardí-Yanes, P, Marques-Pamies, M, Rodríguez-Lloveras, H, Rueda-Pujol, A, Marcos-Ruiz, J, Martinez-Saez, E, Alvarez, CV, Bernabéu, I, Delgado, E, Lamas, C, Picó, A, Webb, SM, Menéndez, E, Martínez-Hernández, R, Sampedro, M, Aulinas, A, Biagetti, B, Marazuela, M, Valassi, E, Jordà, M, Puig-Domingo, M. Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview. Machine Learning And Knowledge Extraction. 2026; 8(1)DOI:10.3390/make8010016. PMID:. IF:(Q/D).
01/01/2026
Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans
Galbiati, F, Plessow, F, Plummer, L, Campbell, MB, Nazarloo, S, Carter, CS, Davis, JM, Miller, KK, Carroll, RS, Kaiser, UB, Seminara, SB, Aulinas, A, Lawson, EA. Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans. JOURNAL OF NEUROENDOCRINOLOGY. 2026; 38(1)DOI:10.1111/jne.70114. PMID:41273106. IF:4.100(Q1/3D).